Comparative clinical and placental pathologic characteristics in pregnancies with and without SARS-CoV-2 infection
Author:
Turdybekova Yasminur Gabdulhakovna1ORCID, Kopobayeva Irina L.1ORCID, Kamyshanskiy Yevgeniy K.1ORCID, Turmukhambetova Anar A.1
Affiliation:
1. Medical University of Karaganda , Karaganda , Kazakhstan
Abstract
Abstract
Objectives
To compare the clinical and morphological characteristics of the “mother-placenta-fetus” system in high risk pregnant women of three groups: no SARS-CoV-2 infection, mild SARS-CoV-2 infection, and severe SARS-CoV-2 infection.
Methods
A case-control study was performed for all deliveries, at 28 weeks’ gestation or greater, who had standard indications for placental pathologic examination. Three groups were formed: (1) control group (no SARS-CoV-2 infection), (2) mild SARS-CoV-2 infection, (3) severe SARS-CoV-2 infection. High-risk pregnancies were registered in all cases in the study groups. The examination of the placenta and the selection of fragments of placental tissue were carried out in accordance with the consensus recommendations of the Amsterdam Placental Workshop Group. The sections were subjected to standard processing and stained with hematoxylin and eosin according to the standard protocol. All cases were reviewed by two pathologists, which did not know any information on pregnancy outcome and clinical data. Statistical analysis was performed using SPSS, p<0.05 was considered statistically significant.
Results
Women with severe SARS-CoV-2 infection had an increased rate of multimorbidity including diabetes, chronic hypertension and obesity (p<0.01) compared with the other groups. Placentas at severe COVID-19 course were damaged by both chronic and acute injuries, in comparison to the mild and control groups (p<0.001). Also an important finding in severe COVID-19 was diffuse necrosis of the villous trophoblast – homogenization, diffuse circular eosinophilic masses surrounding the chorionic villi.
Conclusions
Women with multimorbidity are an “at-risk” subgroup for severe SARS-CoV-2 infection and greater likelihood of both placental damage and perinatal hypoxic-ischemic events. These results suggest that patient education, SARS-CoV-2 disease monitoring and preventive measures would be of benefit to this group.
Funder
Ministry of Health of the Republic of Kazakhstan
Publisher
Walter de Gruyter GmbH
Subject
Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health
Reference54 articles.
1. Dubey, P, Thakur, B, Reddy, S, Martinez, CA, Nurunnabi, M, Manuel, SL, et al.. Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women – a systematic review and meta-analysis. BMC Pregnancy Childbirth 2021;21:247. https://doi.org/10.1186/s12884-021-03685-w. 2. Chmielewska, B, Barratt, I, Townsend, R, Kalafat, E, van der Meulen, J, Gurol-Urganci, I, et al.. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health 2021;9:759–72. https://doi.org/10.1016/s2214-109x(21)00079-6. 3. Prabhu, M, Cagino, K, Matthews, KC, Friedlander, R, Glynn, S, Kubiak, J, et al.. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York city: a prospective cohort study. BJOG 2020;127:1548–56. https://doi.org/10.1111/1471-0528.16403. 4. Patanè, L, Morotti, D, Giunta, MR, Sigismondi, C, Piccoli, MG, Frigerio, L, et al.. Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth. Am J Obstet Gynecol MFM 2020;2:100145. https://doi.org/10.1016/j.ajogmf.2020.100145. 5. Hosier, H, Farhadian, SF, Morotti, RA, Deshmukh, U, Lu-Culligan, A, Campbell, KH, et al.. SARS-CoV-2 infection of the placenta. J Clin Invest 2020;130:4947–53. https://doi.org/10.1172/jci139569.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|